MarketPeel
Insider Trading Intelligence
Pricing
…
CD

Carl Dambkowski

APGE
CHIEF MEDICAL OFFICER · APOGEE THERAPEUTICS, INC. · CIK 0001983476
FILING MIX · LIFETIME22%/78%
BUYS
22
SELLS
77
TOTAL VALUE
$23.46M
COMPANIES
2
ACTIVE SINCE
Dec 2023
HOLDINGS NOW
216,616
AVG SELL PX
$66.72
TRADE KIND
SHOWING 99 / 99
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
53 backtested trades · 8 horizons · 98 pending
Forward-return performance of every backtestable P/S trade by Carl Dambkowski, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d53+39.62%+1.39%+0.69%+0.70%+0.67%0.54
14d53+43.40%+2.02%+0.40%+1.91%-0.79%0.92
30d53+43.40%+4.48%+0.86%+3.62%+1.98%1.48
60d53(2 pending)+49.02%+8.20%+1.95%+6.92%+2.12%1.85
90d53(2 pending)+33.33%+15.52%+3.84%+12.04%+9.89%2.85
180d53(17 pending)+44.44%+19.38%+7.38%+12.41%-12.09%1.75
1y53(26 pending)+33.33%+61.13%+17.83%+40.62%+40.29%—
2y53(51 pending)+0.00%+254.43%+35.06%+219.37%+219.37%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
APGE · 177,873 shares · as of Jul 1, 2026
074,234148,468222,702296,936202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 22 buys / 77 sellsCOVERAGE · 12 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,500$132.74$730.1K177,873Jul 1, 2026Jul 2, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
4,125$22.86$94.3K183,373Jul 1, 2026Jul 2, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE
Chief Medical Officer
4,125——114,790Jul 1, 2026Jul 2, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
26,400$132.60$3.50M179,248Jun 22, 2026Jun 24, 2026 ↗View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
12,583$70.11$882.2K38,743Jun 12, 2026Jun 12, 2026 ↗View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
22,417$70.13$1.57M51,326Jun 11, 2026Jun 12, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
4,125$22.86$94.3K211,148Jun 3, 2026Jun 5, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,500$78.71$432.9K205,648Jun 3, 2026Jun 5, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE
Chief Medical Officer
4,125——118,915Jun 3, 2026Jun 5, 2026 ↗View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
9,136——9,136Jun 2, 2026Jun 3, 2026 ↗View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASE
11,667$11.77$137.3K178,743May 21, 2026May 22, 2026 ↗View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE
11,904——10,952May 21, 2026May 22, 2026 ↗View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASE
11,904$7.80$92.9K167,076May 21, 2026May 22, 2026 ↗View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE
11,667——5,833May 21, 2026May 22, 2026 ↗View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
13,235$59.97$793.7K73,743May 21, 2026May 22, 2026 ↗View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE
38,689——32,737May 21, 2026May 22, 2026 ↗View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASE
38,689$6.84$264.6K155,172May 21, 2026May 22, 2026 ↗View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
38,318$58.43$2.24M140,425May 21, 2026May 22, 2026 ↗View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
53,447$59.10$3.16M86,978May 21, 2026May 22, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
4,125$22.86$94.3K212,523May 6, 2026May 8, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,800$84.60$152.3K207,023May 6, 2026May 8, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,700$83.92$310.5K208,823May 6, 2026May 8, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE
Chief Medical Officer
4,125——123,040May 6, 2026May 8, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
4,125$22.86$94.3K213,898Apr 1, 2026Apr 3, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
100$85.89$8.6K208,398Apr 1, 2026Apr 3, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,702$85.33$230.6K208,498Apr 1, 2026Apr 3, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE
Chief Medical Officer
4,125——127,165Apr 1, 2026Apr 3, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,698$84.31$227.5K211,200Apr 1, 2026Apr 3, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
200$73.26$14.7K209,773Mar 4, 2026Mar 6, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,075$71.98$149.4K209,973Mar 4, 2026Mar 6, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE
Chief Medical Officer
4,125——131,290Mar 4, 2026Mar 6, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
4,125$22.86$94.3K215,273Mar 4, 2026Mar 6, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,225$70.33$226.8K212,048Mar 4, 2026Mar 6, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,299$66.85$86.8K211,448Feb 4, 2026Feb 4, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,481$64.88$161.0K214,167Feb 4, 2026Feb 4, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,420$65.83$93.5K212,747Feb 4, 2026Feb 4, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
100$67.88$6.8K211,348Feb 4, 2026Feb 4, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
4,125$22.86$94.3K216,648Feb 4, 2026Feb 4, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE
Chief Medical Officer
4,125——135,415Feb 4, 2026Feb 4, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
200$68.94$13.8K211,148Feb 4, 2026Feb 4, 2026 ↗View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASE
116,483——116,483Jan 23, 2026Jan 23, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
14,025$22.86$320.6K231,223Jan 7, 2026Jan 9, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE
Chief Medical Officer
14,025——139,540Jan 7, 2026Jan 9, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,954$77.13$227.8K228,269Jan 7, 2026Jan 9, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
14,820$77.90$1.15M213,449Jan 7, 2026Jan 9, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
100$80.06$8.0K212,523Jan 7, 2026Jan 9, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
826$79.04$65.3K212,623Jan 7, 2026Jan 9, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
83,690——83,690Jan 2, 2026Jan 6, 2026 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
10,900$75.00$817.5K271,108Dec 4, 2025Dec 5, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
8,060$22.86$184.3K292,793Nov 5, 2025Nov 7, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,200$54.83$120.6K288,293Nov 5, 2025Nov 7, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
678$56.51$38.3K282,008Nov 5, 2025Nov 7, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,300$53.62$123.3K290,493Nov 5, 2025Nov 7, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,607$55.58$311.6K282,686Nov 5, 2025Nov 7, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE
Chief Medical Officer
8,060——153,565Nov 5, 2025Nov 7, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,110$39.80$203.4K284,733Oct 1, 2025Oct 3, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
2,385$22.86$54.5K289,843Oct 1, 2025Oct 3, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE
Chief Medical Officer
2,385——161,625Oct 1, 2025Oct 3, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
190$38.55$7.3K233,548Sep 3, 2025Sep 5, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,535$37.82$95.9K233,738Sep 3, 2025Sep 5, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,725$37.78$103.0K236,273Aug 6, 2025Aug 8, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE
Chief Medical Officer
7,365——164,010Jul 2, 2025Jul 3, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
746$46.26$34.5K238,998Jul 2, 2025Jul 3, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,409$44.77$286.9K242,679Jul 2, 2025Jul 3, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,935$45.49$133.5K239,744Jul 2, 2025Jul 3, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
7,365$22.86$168.4K249,088Jul 2, 2025Jul 3, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,725$36.96$100.7K241,723Jun 4, 2025Jun 6, 2025 ↗View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
17,500——17,500Jun 2, 2025Jun 3, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,725$35.75$97.4K244,448May 7, 2025May 9, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
500$37.03$18.5K248,062Apr 2, 2025Apr 4, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,471$35.56$87.9K248,562Apr 2, 2025Apr 4, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
889$37.59$33.4K247,173Apr 2, 2025Apr 4, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,590$30.48$48.5K251,033Mar 5, 2025Mar 7, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,520$40.69$143.2K252,623Feb 5, 2025Feb 7, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
795$22.86$18.2K256,143Feb 5, 2025Feb 7, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE
Chief Medical Officer
795——171,375Feb 5, 2025Feb 7, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
1,360$22.86$31.1K259,433Jan 2, 2025Jan 3, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,499$46.42$69.6K257,934Jan 2, 2025Jan 3, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE
Chief Medical Officer
1,360——172,170Jan 2, 2025Jan 3, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,486$47.21$117.4K255,448Jan 2, 2025Jan 3, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
100$47.92$4.8K255,348Jan 2, 2025Jan 3, 2025 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
1,815$22.86$41.5K262,613Dec 11, 2024Dec 13, 2024 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE
Chief Medical Officer
1,815——173,530Dec 11, 2024Dec 13, 2024 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
455$50.00$22.8K258,073Dec 11, 2024Dec 13, 2024 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,085$48.62$198.6K258,528Dec 11, 2024Dec 13, 2024 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
124,962——124,962Dec 9, 2024Dec 11, 2024 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,665$46.07$307.1K260,798Dec 4, 2024Dec 6, 2024 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,339$59.96$80.3K267,463Nov 6, 2024Nov 8, 2024 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,326$58.91$313.8K268,802Nov 6, 2024Nov 8, 2024 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,740$56.16$322.4K275,053Oct 2, 2024Oct 4, 2024 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
925$56.86$52.6K274,128Oct 2, 2024Oct 4, 2024 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
787$48.06$37.8K280,793Sep 4, 2024Sep 6, 2024 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,878$47.49$279.1K281,580Sep 4, 2024Sep 6, 2024 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,523$40.47$264.0K288,270Aug 7, 2024Aug 9, 2024 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
142$41.09$5.8K288,128Aug 7, 2024Aug 9, 2024 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
670$42.56$28.5K287,458Aug 7, 2024Aug 9, 2024 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,852$37.29$143.6K296,936Jul 3, 2024Jul 5, 2024 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,143$38.16$81.8K294,793Jul 3, 2024Jul 5, 2024 ↗View →
APGE
APOGEE THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
175,345——175,345Dec 18, 2023Dec 20, 2023 ↗View →
Other insiders · APGE
Loading peer insiders…
About this filer
CIK 0001983476
ROLE
Chief Medical Officer
PRIMARY
APGE
COMPANIES
2
ACTIVE SINCE
Dec 2023
MARKETPEEL · /INSIDER/0001983476DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback